These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 12468702)

  • 21. Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research.
    Mahon J; Fitzgerald A; Glanville J; Dekhuijzen R; Glatte J; Glanemann S; Torvinen S
    Respir Med; 2017 Aug; 129():98-116. PubMed ID: 28732842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Device errors in asthma and COPD: systematic literature review and meta-analysis.
    Chrystyn H; van der Palen J; Sharma R; Barnes N; Delafont B; Mahajan A; Thomas M
    NPJ Prim Care Respir Med; 2017 Apr; 27(1):22. PubMed ID: 28373682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugs for COPD.
    Med Lett Drugs Ther; 2017 Apr; 59(1518):57-62. PubMed ID: 28377550
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
    Petite SE
    Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ambulatory criteria of dry powder inhaler selection based on peak inspiratory flow recordings].
    Droszcz W; Droscez P
    Pneumonol Alergol Pol; 2002; 70(9-10):490-5. PubMed ID: 12710102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences.
    Ninane V; Vandevoorde J; Cataldo D; Derom E; Liistro G; Munghen E; Peché R; Schlesser M; Verleden G; Vincken W
    Respir Med; 2015 Nov; 109(11):1430-8. PubMed ID: 26439177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rating criteria for selection of an inhaler and instructing its use in patients with asthma and COPD].
    Ludwikowski R; Płusa T; Bijoś P
    Pol Merkur Lekarski; 2016 Dec; 41(246):279-282. PubMed ID: 28024131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler.
    Serra-Batlles J; Plaza V; Badiola C; Morejón E;
    J Aerosol Med; 2002; 15(1):59-64. PubMed ID: 12006146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low incidence of paradoxical bronchoconstriction in asthma and COPD patients during chronic use of Respimat soft mist inhaler.
    Hodder R; Pavia D; Dewberry H; Alexander K; Iacono P; Ponitz H; Beck E
    Respir Med; 2005 Sep; 99(9):1087-95. PubMed ID: 15893465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost Evaluation of Inhaler Therapies Used in Respiratory Diseases: 1998--2015 Period in Turkey.
    Bayar B; Kutkan NU; Şafak Yılmaz E; Tolun Ç; Doğan E; Atikeler EK; Vural EH; Babacan S; Karabekmez N; Beyan A; Vural İM; Oğuzülgen İK; Bektemür G; Malhan S; Kahveci R; Altın S; Alkan A; Eroğlu H; Gürsöz H
    Value Health Reg Issues; 2017 Sep; 13():31-38. PubMed ID: 29073985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The knowledge and considerations of the physicians regarding the inhaler devices in asthma and COPD: the INTEDA-1 study.
    Calışkaner AZ; Öztürk C; Ceylan E; Pekcan S; Yılmaz Ö; Öztürk S; Can C; Şener O; Yılmaz Turay Ü; Koç N; Ersoy R
    Tuberk Toraks; 2013; 61(3):183-92. PubMed ID: 24298959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Respimat Soft Mist Inhaler, a Novel Inhaled Drug Delivery Device.
    Perriello EA; Sobieraj DM
    Conn Med; 2016; 80(6):359-64. PubMed ID: 27509644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matching Inhaler Devices with Patients: The Role of the Primary Care Physician.
    Kaplan A; Price D
    Can Respir J; 2018; 2018():9473051. PubMed ID: 29951160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asthma COPD Overlap Syndrome: An Approach to A Real -World Endotype in Obstructive Lung Disease?
    Laucho-Contreras M; de Oca MM; Owen CA
    Curr Pharm Des; 2016; 22(41):6273-6282. PubMed ID: 27604607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy without success. Every 3d powder inhaler is used improperly (interview by Maria Weiss)].
    Wieshammer S
    MMW Fortschr Med; 2007 Nov; 149(48):8. PubMed ID: 18161431
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug therapy of airway obstruction. "Completely different for asthma and COPD"].
    MMW Fortschr Med; 2008 May; 150(20):14, 16. PubMed ID: 18605635
    [No Abstract]   [Full Text] [Related]  

  • 38. Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR).
    Lavorini F; Braido F; Baiardini I; Blasi F; Canonica GW;
    Pulm Pharmacol Ther; 2015 Oct; 34():25-30. PubMed ID: 26209820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usage and usability of one dry powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany.
    Hantulik P; Wittig K; Henschel Y; Ochse J; Vahteristo M; Rytila P
    Pneumonol Alergol Pol; 2015; 83(5):365-77. PubMed ID: 26378998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Novolizer: a multidose dry powder inhaler: a viewpoint by Peter Haidl.
    Haidl P
    Treat Respir Med; 2005; 4(1):70. PubMed ID: 15725052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.